1-(异丙基氨基)-3-(2,4,5-三甲基苯氧基)-2-丙醇 | 17765-94-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 1-(异丙基氨基)-3-(2,4,5-三甲基苯氧基)-2-丙醇
• 英文名称: RS-1-(isopropylamino)-3-(2,4,5-trimethylphenoxy)propan-2-ol
• 英文别名: (isopropylamino)-3-(2,4,5-trimethylphenoxy)propan-2-ol；1-(Isopropylamino)-3-(2,4,5-trimethylphenoxy)-2-propanol；1-(propan-2-ylamino)-3-(2,4,5-trimethylphenoxy)propan-2-ol
• CAS: 17765-94-5
• 化学式: C₁₅H₂₅NO₂
• 分子量: 251.369
• InChiKey: ZIEQIKOSADHSOJ-UHFFFAOYSA-N

物化性质

• 沸点：
  393.3±42.0 °C(Predicted)
• 密度：
  0.997±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  18
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  41.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF
  申请人：Exciva GmbH

  公开号：EP3618819A1

  公开（公告）日：2020-03-11
• [EN] TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF<br/>[FR] TARGETED DRUG RESCUE AVEC DE NOUVELLES COMPOSITIONS, ASSOCIATIONS ET PROCÉDÉS CORRESPONDANTS
  申请人：EXCIVA UG HAFTUNGSBESCHRAENKT

  公开号：WO2018204713A1

  公开（公告）日：2018-11-08

  Compounds of Formula I, pharmaceutically acceptable salts thereof, enantiomers thereof, metabolites thereof, derivatives thereof, prodrugs thereof, acid addition salts thereof, pharmaceutically acceptable salts thereof, or N-oxides thereof; or a combination thereof, processes and intermediates for preparation thereof, compositions thereof, and uses thereof, are provided. Pharmaceutical compositions comprising a compound of Formula I, or enantiomers thereof, metabolites thereof, derivatives thereof, prodrugs thereof, acid addition salts thereof, pharmaceutically acceptable salts thereof, or N-oxides thereof; or a combination thereof, wherein the compound is double and/or triple agent or ligand for CYP2D6, 5-HT2A, and/or 5HT2C receptors, and/or acetylcholinesterase are provided.